Silver Oak Advisory Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,371
Closed -$386K 76
2025
Q3
$386K Sell
1,371
-2
-0.1% -$580 0.17% 53
2025
Q2
$383K Buy
1,373
+233
+20% +$66K 0.19% 51
2025
Q1
$355K Buy
1,140
+2
+0.2% +$591 0.19% 49
2024
Q4
$296K Sell
1,138
-8
-0.7% -$2.37K 0.16% 48
2024
Q3
$369K Buy
1,146
+10
+0.9% +$3.27K 0.19% 48
2024
Q2
$354K Buy
1,136
+2
+0.2% +$588 0.2% 47
2024
Q1
$323K Buy
1,134
+1
+0.1% +$293 0.18% 50
2023
Q4
$326K Sell
1,133
-6
-0.5% -$1.64K 0.19% 47
2023
Q3
$306K Buy
+1,139
New +$284K 0.2% 45

Other funds holding AMGN

Silver Oak Advisory Group's AMGN Position: Q4 2025 in Review

Silver Oak Advisory Group sold out of Amgen (AMGN) in Q4 2025, closing a stake of 1,371 shares — an estimated $386K sold.

Silver Oak Advisory Group first reported a position in AMGN in Q3 2023 and held it in 9 quarters. The position peaked at $386K in Q3 2025. 3,086 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Silver Oak Advisory Group reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Silver Oak Advisory Group sold 1,371 Amgen shares in Q4 2025, an estimated $386K.
  • Silver Oak Advisory Group first reported a position in Amgen in Q3 2023 and held it in 9 quarters.
  • Silver Oak Advisory Group's Amgen position peaked at $386K in Q3 2025.
  • 3,086 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Silver Oak Advisory Group's 13F filing for Q4 2025, filed 3 Feb 2026.